nodes	percent_of_prediction	percent_of_DWPC	metapath
Gallium nitrate—BGLAP—osteoporosis	0.403	0.582	CbGaD
Gallium nitrate—IL1B—osteoporosis	0.289	0.418	CbGaD
Gallium nitrate—BGLAP—forelimb zeugopod—osteoporosis	0.0146	0.142	CbGeAlD
Gallium nitrate—BGLAP—mandible—osteoporosis	0.0144	0.14	CbGeAlD
Gallium nitrate—BGLAP—jaw skeleton—osteoporosis	0.0122	0.119	CbGeAlD
Gallium nitrate—BGLAP—periosteum—osteoporosis	0.00925	0.09	CbGeAlD
Gallium nitrate—IL1B—periosteum—osteoporosis	0.00791	0.0769	CbGeAlD
Gallium nitrate—BGLAP—vertebral column—osteoporosis	0.00766	0.0745	CbGeAlD
Gallium nitrate—BGLAP—skull—osteoporosis	0.0076	0.0739	CbGeAlD
Gallium nitrate—BGLAP—parathyroid gland—osteoporosis	0.00742	0.0722	CbGeAlD
Gallium nitrate—IL1B—vertebral column—osteoporosis	0.00655	0.0637	CbGeAlD
Gallium nitrate—TF—vertebral column—osteoporosis	0.00584	0.0568	CbGeAlD
Gallium nitrate—Edema of lower extremities—Zoledronate—osteoporosis	0.0037	0.0407	CcSEcCtD
Gallium nitrate—Rales—Pamidronate—osteoporosis	0.00198	0.0218	CcSEcCtD
Gallium nitrate—Hypothermia—Ibandronate—osteoporosis	0.00185	0.0203	CcSEcCtD
Gallium nitrate—Body temperature decreased—Ibandronate—osteoporosis	0.00185	0.0203	CcSEcCtD
Gallium nitrate—Hypophosphataemia—Ibandronate—osteoporosis	0.00178	0.0196	CcSEcCtD
Gallium nitrate—Optic neuritis—Estropipate—osteoporosis	0.00176	0.0193	CcSEcCtD
Gallium nitrate—Coma—Calcium Acetate—osteoporosis	0.00174	0.0191	CcSEcCtD
Gallium nitrate—ATP6V1B2—uterus—osteoporosis	0.00148	0.0144	CbGeAlD
Gallium nitrate—Hypophosphataemia—Pamidronate—osteoporosis	0.0014	0.0154	CcSEcCtD
Gallium nitrate—Hypophosphataemia—Zoledronate—osteoporosis	0.00128	0.014	CcSEcCtD
Gallium nitrate—Neoplasm malignant—Estropipate—osteoporosis	0.00127	0.0139	CcSEcCtD
Gallium nitrate—ATP6V1B2—bone marrow—osteoporosis	0.00125	0.0122	CbGeAlD
Gallium nitrate—Neoplasm malignant—Raloxifene—osteoporosis	0.00123	0.0135	CcSEcCtD
Gallium nitrate—Neoplasm malignant—Calcitriol—osteoporosis	0.00119	0.0131	CcSEcCtD
Gallium nitrate—Hypocalcaemia—Estropipate—osteoporosis	0.00118	0.013	CcSEcCtD
Gallium nitrate—Hypocalcaemia—Alendronate—osteoporosis	0.00116	0.0128	CcSEcCtD
Gallium nitrate—Optic neuritis—Conjugated Estrogens—osteoporosis	0.00116	0.0128	CcSEcCtD
Gallium nitrate—Hypocalcaemia—Ibandronate—osteoporosis	0.00113	0.0125	CcSEcCtD
Gallium nitrate—IL1B—uterus—osteoporosis	0.00108	0.0105	CbGeAlD
Gallium nitrate—BGLAP—bone marrow—osteoporosis	0.00107	0.0104	CbGeAlD
Gallium nitrate—Pleural effusion—Pamidronate—osteoporosis	0.00106	0.0117	CcSEcCtD
Gallium nitrate—Blindness—Estradiol—osteoporosis	0.00103	0.0114	CcSEcCtD
Gallium nitrate—Pleural effusion—Zoledronate—osteoporosis	0.000969	0.0107	CcSEcCtD
Gallium nitrate—TF—uterus—osteoporosis	0.000964	0.00938	CbGeAlD
Gallium nitrate—RRM2—uterus—osteoporosis	0.000952	0.00927	CbGeAlD
Gallium nitrate—Neoplasm malignant—Pamidronate—osteoporosis	0.000951	0.0105	CcSEcCtD
Gallium nitrate—Hypocalcaemia—Risedronate—osteoporosis	0.000933	0.0103	CcSEcCtD
Gallium nitrate—Optic neuritis—Estradiol—osteoporosis	0.00093	0.0102	CcSEcCtD
Gallium nitrate—IL1B—bone marrow—osteoporosis	0.000918	0.00893	CbGeAlD
Gallium nitrate—Hypocalcaemia—Pamidronate—osteoporosis	0.000887	0.00976	CcSEcCtD
Gallium nitrate—Neoplasm malignant—Zoledronate—osteoporosis	0.000869	0.00956	CcSEcCtD
Gallium nitrate—Neoplasm malignant—Conjugated Estrogens—osteoporosis	0.000837	0.0092	CcSEcCtD
Gallium nitrate—TF—bone marrow—osteoporosis	0.000818	0.00796	CbGeAlD
Gallium nitrate—Renal failure acute—Ibandronate—osteoporosis	0.000815	0.00897	CcSEcCtD
Gallium nitrate—Hypocalcaemia—Zoledronate—osteoporosis	0.00081	0.00891	CcSEcCtD
Gallium nitrate—RRM2—bone marrow—osteoporosis	0.000808	0.00786	CbGeAlD
Gallium nitrate—Hypocalcaemia—Conjugated Estrogens—osteoporosis	0.00078	0.00858	CcSEcCtD
Gallium nitrate—Confusional state—Calcium Acetate—osteoporosis	0.000685	0.00753	CcSEcCtD
Gallium nitrate—Anaemia—Ergocalciferol—osteoporosis	0.000679	0.00747	CcSEcCtD
Gallium nitrate—Neoplasm malignant—Estradiol—osteoporosis	0.00067	0.00736	CcSEcCtD
Gallium nitrate—ATP6V1B2—Signaling by Insulin receptor—KL—osteoporosis	0.000639	0.00556	CbGpPWpGaD
Gallium nitrate—Renal failure acute—Pamidronate—osteoporosis	0.000639	0.00702	CcSEcCtD
Gallium nitrate—TF—Platelet degranulation—FGA—osteoporosis	0.000634	0.00551	CbGpPWpGaD
Gallium nitrate—Hypocalcaemia—Estradiol—osteoporosis	0.000625	0.00687	CcSEcCtD
Gallium nitrate—Hallucination—Etidronic acid—osteoporosis	0.000624	0.00687	CcSEcCtD
Gallium nitrate—Paraesthesia—Calcium Acetate—osteoporosis	0.00061	0.00671	CcSEcCtD
Gallium nitrate—BGLAP—FGF signaling pathway—SPP1—osteoporosis	0.000607	0.00528	CbGpPWpGaD
Gallium nitrate—TF—Response to elevated platelet cytosolic Ca2+—FGA—osteoporosis	0.000604	0.00525	CbGpPWpGaD
Gallium nitrate—Lethargy—Pamidronate—osteoporosis	0.000602	0.00662	CcSEcCtD
Gallium nitrate—Hearing impaired—Estradiol—osteoporosis	0.000601	0.00661	CcSEcCtD
Gallium nitrate—TF—Platelet activation, signaling and aggregation—CAP1—osteoporosis	0.000601	0.00522	CbGpPWpGaD
Gallium nitrate—Renal failure acute—Zoledronate—osteoporosis	0.000583	0.00642	CcSEcCtD
Gallium nitrate—Constipation—Calcium Acetate—osteoporosis	0.000581	0.00639	CcSEcCtD
Gallium nitrate—TF—Platelet degranulation—FGB—osteoporosis	0.000577	0.00502	CbGpPWpGaD
Gallium nitrate—IL1B—Alzheimers Disease—GAPDH—osteoporosis	0.000562	0.00489	CbGpPWpGaD
Gallium nitrate—Renal failure acute—Conjugated Estrogens—osteoporosis	0.000562	0.00618	CcSEcCtD
Gallium nitrate—Feeling abnormal—Calcium Acetate—osteoporosis	0.00056	0.00616	CcSEcCtD
Gallium nitrate—IL1B—Signaling by Interleukins—IRAK3—osteoporosis	0.000558	0.00485	CbGpPWpGaD
Gallium nitrate—Lethargy—Zoledronate—osteoporosis	0.00055	0.00604	CcSEcCtD
Gallium nitrate—TF—Response to elevated platelet cytosolic Ca2+—FGB—osteoporosis	0.000549	0.00478	CbGpPWpGaD
Gallium nitrate—Erythema—Etidronic acid—osteoporosis	0.000546	0.00601	CcSEcCtD
Gallium nitrate—RRM2—Fluoropyrimidine Activity—MTHFR—osteoporosis	0.000544	0.00473	CbGpPWpGaD
Gallium nitrate—Oedema peripheral—Estropipate—osteoporosis	0.000535	0.00588	CcSEcCtD
Gallium nitrate—Oedema peripheral—Alendronate—osteoporosis	0.000527	0.00579	CcSEcCtD
Gallium nitrate—Oedema peripheral—Raloxifene—osteoporosis	0.000518	0.0057	CcSEcCtD
Gallium nitrate—Constipation—Ergocalciferol—osteoporosis	0.000513	0.00564	CcSEcCtD
Gallium nitrate—Oedema peripheral—Ibandronate—osteoporosis	0.000513	0.00564	CcSEcCtD
Gallium nitrate—Anaemia—Etidronic acid—osteoporosis	0.000505	0.00555	CcSEcCtD
Gallium nitrate—Hypersensitivity—Calcium Acetate—osteoporosis	0.0005	0.0055	CcSEcCtD
Gallium nitrate—Leukopenia—Etidronic acid—osteoporosis	0.000489	0.00538	CcSEcCtD
Gallium nitrate—IL1B—TCR Signaling Pathway—NFATC1—osteoporosis	0.000481	0.00419	CbGpPWpGaD
Gallium nitrate—Pruritus—Calcium Acetate—osteoporosis	0.000481	0.00529	CcSEcCtD
Gallium nitrate—TF—Platelet activation, signaling and aggregation—MGLL—osteoporosis	0.000477	0.00415	CbGpPWpGaD
Gallium nitrate—Erythema—Estropipate—osteoporosis	0.000473	0.0052	CcSEcCtD
Gallium nitrate—Erythema—Alendronate—osteoporosis	0.000466	0.00512	CcSEcCtD
Gallium nitrate—Diarrhoea—Calcium Acetate—osteoporosis	0.000465	0.00511	CcSEcCtD
Gallium nitrate—IL1B—Regulation of toll-like receptor signaling pathway—IRAK3—osteoporosis	0.000456	0.00397	CbGpPWpGaD
Gallium nitrate—Erythema—Ibandronate—osteoporosis	0.000453	0.00499	CcSEcCtD
Gallium nitrate—Confusional state—Etidronic acid—osteoporosis	0.00045	0.00494	CcSEcCtD
Gallium nitrate—Erythema—Calcitriol—osteoporosis	0.000444	0.00488	CcSEcCtD
Gallium nitrate—ATP6V1B2—Signaling by Insulin receptor—IRS2—osteoporosis	0.000438	0.00381	CbGpPWpGaD
Gallium nitrate—TF—Platelet activation, signaling and aggregation—PLEK—osteoporosis	0.000436	0.0038	CbGpPWpGaD
Gallium nitrate—Vomiting—Calcium Acetate—osteoporosis	0.000432	0.00475	CcSEcCtD
Gallium nitrate—Anaemia—Alendronate—osteoporosis	0.00043	0.00473	CcSEcCtD
Gallium nitrate—IL1B—Vitamin B12 Metabolism—SOD2—osteoporosis	0.000429	0.00373	CbGpPWpGaD
Gallium nitrate—Lethargy—Estradiol—osteoporosis	0.000424	0.00466	CcSEcCtD
Gallium nitrate—Oedema peripheral—Risedronate—osteoporosis	0.000423	0.00465	CcSEcCtD
Gallium nitrate—TF—SIDS Susceptibility Pathways—GAPDH—osteoporosis	0.000421	0.00366	CbGpPWpGaD
Gallium nitrate—Anaemia—Ibandronate—osteoporosis	0.000419	0.00461	CcSEcCtD
Gallium nitrate—Nausea—Calcium Acetate—osteoporosis	0.000403	0.00444	CcSEcCtD
Gallium nitrate—Paraesthesia—Etidronic acid—osteoporosis	0.0004	0.0044	CcSEcCtD
Gallium nitrate—Tinnitus—Risedronate—osteoporosis	0.0004	0.0044	CcSEcCtD
Gallium nitrate—TF—Differentiation Pathway—IL6R—osteoporosis	0.000398	0.00347	CbGpPWpGaD
Gallium nitrate—TF—Differentiation Pathway—IGF1—osteoporosis	0.000393	0.00342	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—WDR1—osteoporosis	0.000392	0.00341	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling by Insulin receptor—IRS1—osteoporosis	0.000382	0.00332	CbGpPWpGaD
Gallium nitrate—IL1B—Myometrial Relaxation and Contraction Pathways—ACTG1—osteoporosis	0.000382	0.00332	CbGpPWpGaD
Gallium nitrate—Constipation—Etidronic acid—osteoporosis	0.000381	0.00419	CcSEcCtD
Gallium nitrate—IL1B—Vitamin B12 Metabolism—MTHFR—osteoporosis	0.000377	0.00328	CbGpPWpGaD
Gallium nitrate—TF—Platelet activation, signaling and aggregation—TLN1—osteoporosis	0.000376	0.00327	CbGpPWpGaD
Gallium nitrate—TF—Platelet activation, signaling and aggregation—VCL—osteoporosis	0.000371	0.00323	CbGpPWpGaD
Gallium nitrate—TF—HIF-1-alpha transcription factor network—LEP—osteoporosis	0.000369	0.00321	CbGpPWpGaD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—BMP2—osteoporosis	0.000368	0.0032	CbGpPWpGaD
Gallium nitrate—Feeling abnormal—Etidronic acid—osteoporosis	0.000367	0.00404	CcSEcCtD
Gallium nitrate—Oedema peripheral—Zoledronate—osteoporosis	0.000367	0.00404	CcSEcCtD
Gallium nitrate—ATP6V1B2—Signaling by Insulin receptor—IL6R—osteoporosis	0.000359	0.00312	CbGpPWpGaD
Gallium nitrate—Nausea—Ergocalciferol—osteoporosis	0.000356	0.00392	CcSEcCtD
Gallium nitrate—ATP6V1B2—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000355	0.00309	CbGpPWpGaD
Gallium nitrate—Erythema—Pamidronate—osteoporosis	0.000355	0.00391	CcSEcCtD
Gallium nitrate—Oedema peripheral—Conjugated Estrogens—osteoporosis	0.000353	0.00389	CcSEcCtD
Gallium nitrate—IL1B—Folate Metabolism—SOD2—osteoporosis	0.000349	0.00303	CbGpPWpGaD
Gallium nitrate—Paraesthesia—Estropipate—osteoporosis	0.000346	0.00381	CcSEcCtD
Gallium nitrate—Anaemia—Risedronate—osteoporosis	0.000345	0.0038	CcSEcCtD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—COL1A1—osteoporosis	0.000344	0.00299	CbGpPWpGaD
Gallium nitrate—RRM2—G1/S Transition—PSMA5—osteoporosis	0.000343	0.00299	CbGpPWpGaD
Gallium nitrate—RRM2—G1/S Transition—PSMA2—osteoporosis	0.000343	0.00299	CbGpPWpGaD
Gallium nitrate—IL1B—Folate Metabolism—GPX1—osteoporosis	0.000333	0.00289	CbGpPWpGaD
Gallium nitrate—Paraesthesia—Ibandronate—osteoporosis	0.000332	0.00365	CcSEcCtD
Gallium nitrate—BGLAP—Glucocorticoid receptor regulatory network—POMC—osteoporosis	0.00033	0.00287	CbGpPWpGaD
Gallium nitrate—Constipation—Estropipate—osteoporosis	0.00033	0.00363	CcSEcCtD
Gallium nitrate—Hypersensitivity—Etidronic acid—osteoporosis	0.000329	0.00361	CcSEcCtD
Gallium nitrate—Anaemia—Pamidronate—osteoporosis	0.000328	0.00361	CcSEcCtD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—GAPDH—osteoporosis	0.000326	0.00284	CbGpPWpGaD
Gallium nitrate—Constipation—Alendronate—osteoporosis	0.000325	0.00357	CcSEcCtD
Gallium nitrate—Erythema—Zoledronate—osteoporosis	0.000324	0.00357	CcSEcCtD
Gallium nitrate—IL1B—Cellular roles of Anthrax toxin—TNF—osteoporosis	0.000318	0.00277	CbGpPWpGaD
Gallium nitrate—Leukopenia—Pamidronate—osteoporosis	0.000318	0.0035	CcSEcCtD
Gallium nitrate—Constipation—Ibandronate—osteoporosis	0.000316	0.00348	CcSEcCtD
Gallium nitrate—Pruritus—Etidronic acid—osteoporosis	0.000315	0.00347	CcSEcCtD
Gallium nitrate—BGLAP—Interleukin-11 Signaling Pathway—TGFB1—osteoporosis	0.000313	0.00273	CbGpPWpGaD
Gallium nitrate—Feeling abnormal—Alendronate—osteoporosis	0.000313	0.00344	CcSEcCtD
Gallium nitrate—Erythema—Conjugated Estrogens—osteoporosis	0.000312	0.00344	CcSEcCtD
Gallium nitrate—TF—Platelet activation, signaling and aggregation—RAP1A—osteoporosis	0.00031	0.0027	CbGpPWpGaD
Gallium nitrate—Constipation—Calcitriol—osteoporosis	0.00031	0.00341	CcSEcCtD
Gallium nitrate—TF—Hemostasis—CAP1—osteoporosis	0.00031	0.00269	CbGpPWpGaD
Gallium nitrate—IL1B—Folate Metabolism—MTHFR—osteoporosis	0.000307	0.00267	CbGpPWpGaD
Gallium nitrate—Diarrhoea—Etidronic acid—osteoporosis	0.000305	0.00336	CcSEcCtD
Gallium nitrate—Body temperature increased—Estropipate—osteoporosis	0.000305	0.00335	CcSEcCtD
Gallium nitrate—Feeling abnormal—Ibandronate—osteoporosis	0.000305	0.00335	CcSEcCtD
Gallium nitrate—ATP6V1B2—Disease—PKM—osteoporosis	0.000302	0.00263	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—SOST—osteoporosis	0.000302	0.00263	CbGpPWpGaD
Gallium nitrate—Body temperature increased—Alendronate—osteoporosis	0.0003	0.0033	CcSEcCtD
Gallium nitrate—Anaemia—Zoledronate—osteoporosis	0.0003	0.0033	CcSEcCtD
Gallium nitrate—IL1B—MAPK Signaling Pathway—RAP1A—osteoporosis	0.000299	0.0026	CbGpPWpGaD
Gallium nitrate—IL1B—IL27-mediated signaling events—TGFB1—osteoporosis	0.000298	0.0026	CbGpPWpGaD
Gallium nitrate—RRM2—Nucleotide metabolism—GPX1—osteoporosis	0.000296	0.00258	CbGpPWpGaD
Gallium nitrate—Body temperature increased—Raloxifene—osteoporosis	0.000295	0.00325	CcSEcCtD
Gallium nitrate—Body temperature increased—Ibandronate—osteoporosis	0.000292	0.00322	CcSEcCtD
Gallium nitrate—Confusional state—Pamidronate—osteoporosis	0.000292	0.00321	CcSEcCtD
Gallium nitrate—IL1B—MAPK Signaling Pathway—NFATC1—osteoporosis	0.000292	0.00254	CbGpPWpGaD
Gallium nitrate—TF—SIDS Susceptibility Pathways—ESR2—osteoporosis	0.000292	0.00254	CbGpPWpGaD
Gallium nitrate—Leukopenia—Zoledronate—osteoporosis	0.00029	0.00319	CcSEcCtD
Gallium nitrate—IL1B—Cytokines and Inflammatory Response—TGFB1—osteoporosis	0.000289	0.00252	CbGpPWpGaD
Gallium nitrate—RRM2—Mitotic G1-G1/S phases—PSMA2—osteoporosis	0.000289	0.00252	CbGpPWpGaD
Gallium nitrate—RRM2—Mitotic G1-G1/S phases—PSMA5—osteoporosis	0.000289	0.00252	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—ANTXR2—osteoporosis	0.000287	0.00249	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—PGLS—osteoporosis	0.000287	0.00249	CbGpPWpGaD
Gallium nitrate—Body temperature increased—Calcitriol—osteoporosis	0.000286	0.00315	CcSEcCtD
Gallium nitrate—Hypersensitivity—Estropipate—osteoporosis	0.000284	0.00313	CcSEcCtD
Gallium nitrate—Vomiting—Etidronic acid—osteoporosis	0.000283	0.00312	CcSEcCtD
Gallium nitrate—Oedema peripheral—Estradiol—osteoporosis	0.000283	0.00311	CcSEcCtD
Gallium nitrate—Tachycardia—Pamidronate—osteoporosis	0.000283	0.00311	CcSEcCtD
Gallium nitrate—TF—Platelet activation, signaling and aggregation—FGA—osteoporosis	0.000281	0.00245	CbGpPWpGaD
Gallium nitrate—Rash—Etidronic acid—osteoporosis	0.000281	0.00309	CcSEcCtD
Gallium nitrate—Dermatitis—Etidronic acid—osteoporosis	0.000281	0.00309	CcSEcCtD
Gallium nitrate—Hypersensitivity—Alendronate—osteoporosis	0.00028	0.00308	CcSEcCtD
Gallium nitrate—IL1B—IL27-mediated signaling events—TNF—osteoporosis	0.000279	0.00242	CbGpPWpGaD
Gallium nitrate—IL1B—Selenium Micronutrient Network—SOD2—osteoporosis	0.000277	0.00241	CbGpPWpGaD
Gallium nitrate—Paraesthesia—Risedronate—osteoporosis	0.000274	0.00301	CcSEcCtD
Gallium nitrate—Pruritus—Estropipate—osteoporosis	0.000273	0.003	CcSEcCtD
Gallium nitrate—Hypersensitivity—Ibandronate—osteoporosis	0.000273	0.003	CcSEcCtD
Gallium nitrate—Dyspnoea—Risedronate—osteoporosis	0.000272	0.00299	CcSEcCtD
Gallium nitrate—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—osteoporosis	0.000271	0.00236	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokines and Inflammatory Response—TNF—osteoporosis	0.00027	0.00235	CbGpPWpGaD
Gallium nitrate—Pruritus—Alendronate—osteoporosis	0.000269	0.00296	CcSEcCtD
Gallium nitrate—Tinnitus—Estradiol—osteoporosis	0.000268	0.00294	CcSEcCtD
Gallium nitrate—Constipation—Ethinyl Estradiol—osteoporosis	0.000267	0.00294	CcSEcCtD
Gallium nitrate—Confusional state—Zoledronate—osteoporosis	0.000267	0.00294	CcSEcCtD
Gallium nitrate—Hypersensitivity—Calcitriol—osteoporosis	0.000267	0.00293	CcSEcCtD
Gallium nitrate—Nausea—Etidronic acid—osteoporosis	0.000265	0.00291	CcSEcCtD
Gallium nitrate—IL1B—Selenium Micronutrient Network—GPX1—osteoporosis	0.000264	0.0023	CbGpPWpGaD
Gallium nitrate—Diarrhoea—Estropipate—osteoporosis	0.000264	0.0029	CcSEcCtD
Gallium nitrate—Pruritus—Ibandronate—osteoporosis	0.000262	0.00288	CcSEcCtD
Gallium nitrate—TF—Platelet degranulation—IGF1—osteoporosis	0.000261	0.00227	CbGpPWpGaD
Gallium nitrate—Constipation—Risedronate—osteoporosis	0.000261	0.00287	CcSEcCtD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—IRAK3—osteoporosis	0.00026	0.00226	CbGpPWpGaD
Gallium nitrate—Paraesthesia—Pamidronate—osteoporosis	0.00026	0.00286	CcSEcCtD
Gallium nitrate—Diarrhoea—Alendronate—osteoporosis	0.00026	0.00286	CcSEcCtD
Gallium nitrate—Dyspnoea—Pamidronate—osteoporosis	0.000258	0.00284	CcSEcCtD
Gallium nitrate—Tachycardia—Zoledronate—osteoporosis	0.000258	0.00284	CcSEcCtD
Gallium nitrate—IL1B—Leptin signaling pathway—LEP—osteoporosis	0.000258	0.00224	CbGpPWpGaD
Gallium nitrate—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000258	0.00283	CcSEcCtD
Gallium nitrate—Pruritus—Calcitriol—osteoporosis	0.000256	0.00282	CcSEcCtD
Gallium nitrate—TF—Platelet activation, signaling and aggregation—FGB—osteoporosis	0.000256	0.00223	CbGpPWpGaD
Gallium nitrate—Diarrhoea—Raloxifene—osteoporosis	0.000256	0.00281	CcSEcCtD
Gallium nitrate—Diarrhoea—Ibandronate—osteoporosis	0.000253	0.00278	CcSEcCtD
Gallium nitrate—Erythema—Estradiol—osteoporosis	0.00025	0.00275	CcSEcCtD
Gallium nitrate—TF—Response to elevated platelet cytosolic Ca2+—IGF1—osteoporosis	0.000249	0.00216	CbGpPWpGaD
Gallium nitrate—Tachycardia—Conjugated Estrogens—osteoporosis	0.000249	0.00274	CcSEcCtD
Gallium nitrate—Constipation—Pamidronate—osteoporosis	0.000248	0.00273	CcSEcCtD
Gallium nitrate—Diarrhoea—Calcitriol—osteoporosis	0.000248	0.00273	CcSEcCtD
Gallium nitrate—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000247	0.00272	CcSEcCtD
Gallium nitrate—IL1B—Leptin signaling pathway—ESR1—osteoporosis	0.000246	0.00214	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—MGLL—osteoporosis	0.000246	0.00214	CbGpPWpGaD
Gallium nitrate—Vomiting—Estropipate—osteoporosis	0.000245	0.0027	CcSEcCtD
Gallium nitrate—IL1B—Selenium Micronutrient Network—MTHFR—osteoporosis	0.000244	0.00212	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—GSN—osteoporosis	0.000244	0.00212	CbGpPWpGaD
Gallium nitrate—Rash—Estropipate—osteoporosis	0.000243	0.00268	CcSEcCtD
Gallium nitrate—Dermatitis—Estropipate—osteoporosis	0.000243	0.00267	CcSEcCtD
Gallium nitrate—Vomiting—Alendronate—osteoporosis	0.000242	0.00266	CcSEcCtD
Gallium nitrate—Body temperature increased—Risedronate—osteoporosis	0.000241	0.00265	CcSEcCtD
Gallium nitrate—Rash—Alendronate—osteoporosis	0.00024	0.00263	CcSEcCtD
Gallium nitrate—Dermatitis—Alendronate—osteoporosis	0.000239	0.00263	CcSEcCtD
Gallium nitrate—Feeling abnormal—Pamidronate—osteoporosis	0.000239	0.00263	CcSEcCtD
Gallium nitrate—Paraesthesia—Zoledronate—osteoporosis	0.000238	0.00261	CcSEcCtD
Gallium nitrate—Vomiting—Raloxifene—osteoporosis	0.000238	0.00261	CcSEcCtD
Gallium nitrate—IL1B—Myometrial Relaxation and Contraction Pathways—CALCA—osteoporosis	0.000237	0.00206	CbGpPWpGaD
Gallium nitrate—Dyspnoea—Zoledronate—osteoporosis	0.000236	0.0026	CcSEcCtD
Gallium nitrate—IL1B—Monoamine Transport—TNF—osteoporosis	0.000236	0.00205	CbGpPWpGaD
Gallium nitrate—Rash—Raloxifene—osteoporosis	0.000236	0.00259	CcSEcCtD
Gallium nitrate—TF—Differentiation Pathway—TGFB1—osteoporosis	0.000236	0.00205	CbGpPWpGaD
Gallium nitrate—Dermatitis—Raloxifene—osteoporosis	0.000235	0.00259	CcSEcCtD
Gallium nitrate—Vomiting—Ibandronate—osteoporosis	0.000235	0.00259	CcSEcCtD
Gallium nitrate—Rash—Ibandronate—osteoporosis	0.000233	0.00257	CcSEcCtD
Gallium nitrate—Dermatitis—Ibandronate—osteoporosis	0.000233	0.00256	CcSEcCtD
Gallium nitrate—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00023	0.00253	CcSEcCtD
Gallium nitrate—Vomiting—Calcitriol—osteoporosis	0.00023	0.00253	CcSEcCtD
Gallium nitrate—IL1B—Leptin signaling pathway—IRS1—osteoporosis	0.00023	0.002	CbGpPWpGaD
Gallium nitrate—Nausea—Estropipate—osteoporosis	0.000229	0.00252	CcSEcCtD
Gallium nitrate—Body temperature increased—Pamidronate—osteoporosis	0.000229	0.00252	CcSEcCtD
Gallium nitrate—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000229	0.00252	CcSEcCtD
Gallium nitrate—Rash—Calcitriol—osteoporosis	0.000228	0.00251	CcSEcCtD
Gallium nitrate—Dermatitis—Calcitriol—osteoporosis	0.000228	0.00251	CcSEcCtD
Gallium nitrate—IL1B—Toll-like Receptor Signaling Pathway—SPP1—osteoporosis	0.000228	0.00198	CbGpPWpGaD
Gallium nitrate—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000227	0.0025	CcSEcCtD
Gallium nitrate—Constipation—Zoledronate—osteoporosis	0.000226	0.00249	CcSEcCtD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—ESR2—osteoporosis	0.000226	0.00197	CbGpPWpGaD
Gallium nitrate—Nausea—Alendronate—osteoporosis	0.000226	0.00248	CcSEcCtD
Gallium nitrate—TF—Hemostasis—ANXA2—osteoporosis	0.000225	0.00196	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—PLEK—osteoporosis	0.000225	0.00196	CbGpPWpGaD
Gallium nitrate—IL1B—IL27-mediated signaling events—IL6—osteoporosis	0.000225	0.00196	CbGpPWpGaD
Gallium nitrate—Hypersensitivity—Risedronate—osteoporosis	0.000225	0.00247	CcSEcCtD
Gallium nitrate—Nausea—Raloxifene—osteoporosis	0.000222	0.00244	CcSEcCtD
Gallium nitrate—Pruritus—Ethinyl Estradiol—osteoporosis	0.000221	0.00243	CcSEcCtD
Gallium nitrate—Nausea—Ibandronate—osteoporosis	0.00022	0.00242	CcSEcCtD
Gallium nitrate—Feeling abnormal—Zoledronate—osteoporosis	0.000218	0.0024	CcSEcCtD
Gallium nitrate—IL1B—Cytokines and Inflammatory Response—IL6—osteoporosis	0.000218	0.0019	CbGpPWpGaD
Gallium nitrate—Constipation—Conjugated Estrogens—osteoporosis	0.000218	0.0024	CcSEcCtD
Gallium nitrate—Pruritus—Risedronate—osteoporosis	0.000216	0.00237	CcSEcCtD
Gallium nitrate—Nausea—Calcitriol—osteoporosis	0.000215	0.00237	CcSEcCtD
Gallium nitrate—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000214	0.00235	CcSEcCtD
Gallium nitrate—Hypersensitivity—Pamidronate—osteoporosis	0.000214	0.00235	CcSEcCtD
Gallium nitrate—ATP6V1B2—Disease—LRP5—osteoporosis	0.000212	0.00185	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—SOST—osteoporosis	0.000212	0.00184	CbGpPWpGaD
Gallium nitrate—IL1B—IL23-mediated signaling events—TNF—osteoporosis	0.00021	0.00183	CbGpPWpGaD
Gallium nitrate—Body temperature increased—Zoledronate—osteoporosis	0.000209	0.0023	CcSEcCtD
Gallium nitrate—Diarrhoea—Risedronate—osteoporosis	0.000209	0.00229	CcSEcCtD
Gallium nitrate—Confusional state—Estradiol—osteoporosis	0.000206	0.00226	CcSEcCtD
Gallium nitrate—Pruritus—Pamidronate—osteoporosis	0.000205	0.00226	CcSEcCtD
Gallium nitrate—ATP6V1B2—Disease—LRP6—osteoporosis	0.000203	0.00176	CbGpPWpGaD
Gallium nitrate—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000201	0.00222	CcSEcCtD
Gallium nitrate—Tachycardia—Estradiol—osteoporosis	0.000199	0.00219	CcSEcCtD
Gallium nitrate—Vomiting—Ethinyl Estradiol—osteoporosis	0.000199	0.00219	CcSEcCtD
Gallium nitrate—Diarrhoea—Pamidronate—osteoporosis	0.000198	0.00218	CcSEcCtD
Gallium nitrate—Rash—Ethinyl Estradiol—osteoporosis	0.000197	0.00217	CcSEcCtD
Gallium nitrate—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000197	0.00217	CcSEcCtD
Gallium nitrate—Hypersensitivity—Zoledronate—osteoporosis	0.000195	0.00215	CcSEcCtD
Gallium nitrate—ATP6V1B2—Disease—RPL24—osteoporosis	0.000195	0.0017	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—LTF—osteoporosis	0.000195	0.0017	CbGpPWpGaD
Gallium nitrate—TF—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000195	0.00169	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—TLN1—osteoporosis	0.000194	0.00169	CbGpPWpGaD
Gallium nitrate—Vomiting—Risedronate—osteoporosis	0.000194	0.00213	CcSEcCtD
Gallium nitrate—Rash—Risedronate—osteoporosis	0.000192	0.00211	CcSEcCtD
Gallium nitrate—Dermatitis—Risedronate—osteoporosis	0.000192	0.00211	CcSEcCtD
Gallium nitrate—ATP6V1B2—Signaling Pathways—PTH1R—osteoporosis	0.000192	0.00167	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—CALCR—osteoporosis	0.000192	0.00167	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—VCL—osteoporosis	0.000191	0.00166	CbGpPWpGaD
Gallium nitrate—IL1B—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	0.000189	0.00164	CbGpPWpGaD
Gallium nitrate—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000188	0.00207	CcSEcCtD
Gallium nitrate—Pruritus—Zoledronate—osteoporosis	0.000187	0.00206	CcSEcCtD
Gallium nitrate—Nausea—Ethinyl Estradiol—osteoporosis	0.000186	0.00204	CcSEcCtD
Gallium nitrate—Vomiting—Pamidronate—osteoporosis	0.000184	0.00203	CcSEcCtD
Gallium nitrate—Paraesthesia—Estradiol—osteoporosis	0.000183	0.00201	CcSEcCtD
Gallium nitrate—Rash—Pamidronate—osteoporosis	0.000183	0.00201	CcSEcCtD
Gallium nitrate—Dermatitis—Pamidronate—osteoporosis	0.000183	0.00201	CcSEcCtD
Gallium nitrate—Dyspnoea—Estradiol—osteoporosis	0.000182	0.002	CcSEcCtD
Gallium nitrate—Diarrhoea—Zoledronate—osteoporosis	0.000181	0.00199	CcSEcCtD
Gallium nitrate—Nausea—Risedronate—osteoporosis	0.000181	0.00199	CcSEcCtD
Gallium nitrate—Pruritus—Conjugated Estrogens—osteoporosis	0.00018	0.00198	CcSEcCtD
Gallium nitrate—IL1B—Spinal Cord Injury—LEP—osteoporosis	0.00018	0.00156	CbGpPWpGaD
Gallium nitrate—IL1B—Regulation of toll-like receptor signaling pathway—SPP1—osteoporosis	0.000178	0.00155	CbGpPWpGaD
Gallium nitrate—TF—Differentiation Pathway—IL6—osteoporosis	0.000178	0.00154	CbGpPWpGaD
Gallium nitrate—IL1B—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	0.000176	0.00154	CbGpPWpGaD
Gallium nitrate—Constipation—Estradiol—osteoporosis	0.000174	0.00192	CcSEcCtD
Gallium nitrate—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000174	0.00192	CcSEcCtD
Gallium nitrate—Nausea—Pamidronate—osteoporosis	0.000172	0.00189	CcSEcCtD
Gallium nitrate—IL1B—IL23-mediated signaling events—IL6—osteoporosis	0.00017	0.00147	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—ACP5—osteoporosis	0.000169	0.00147	CbGpPWpGaD
Gallium nitrate—IL1B—Myometrial Relaxation and Contraction Pathways—ADCY5—osteoporosis	0.000169	0.00147	CbGpPWpGaD
Gallium nitrate—Vomiting—Zoledronate—osteoporosis	0.000168	0.00185	CcSEcCtD
Gallium nitrate—Feeling abnormal—Estradiol—osteoporosis	0.000168	0.00185	CcSEcCtD
Gallium nitrate—Rash—Zoledronate—osteoporosis	0.000167	0.00184	CcSEcCtD
Gallium nitrate—Dermatitis—Zoledronate—osteoporosis	0.000167	0.00183	CcSEcCtD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—IL6R—osteoporosis	0.000165	0.00144	CbGpPWpGaD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—IGF1—osteoporosis	0.000163	0.00142	CbGpPWpGaD
Gallium nitrate—IL1B—Vitamin B12 Metabolism—TNF—osteoporosis	0.000162	0.00141	CbGpPWpGaD
Gallium nitrate—Vomiting—Conjugated Estrogens—osteoporosis	0.000162	0.00178	CcSEcCtD
Gallium nitrate—IL1B—Signaling by Interleukins—IL6R—osteoporosis	0.000162	0.00141	CbGpPWpGaD
Gallium nitrate—Body temperature increased—Estradiol—osteoporosis	0.000161	0.00177	CcSEcCtD
Gallium nitrate—Rash—Conjugated Estrogens—osteoporosis	0.000161	0.00177	CcSEcCtD
Gallium nitrate—Dermatitis—Conjugated Estrogens—osteoporosis	0.000161	0.00177	CcSEcCtD
Gallium nitrate—ATP6V1B2—Signaling by Insulin receptor—IL6—osteoporosis	0.00016	0.00139	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—RAP1A—osteoporosis	0.00016	0.00139	CbGpPWpGaD
Gallium nitrate—IL1B—Hematopoietic Stem Cell Differentiation—IL6—osteoporosis	0.000159	0.00139	CbGpPWpGaD
Gallium nitrate—Nausea—Zoledronate—osteoporosis	0.000157	0.00173	CcSEcCtD
Gallium nitrate—ATP6V1B2—Disease—TPI1—osteoporosis	0.000157	0.00137	CbGpPWpGaD
Gallium nitrate—TF—Platelet degranulation—TGFB1—osteoporosis	0.000157	0.00136	CbGpPWpGaD
Gallium nitrate—TF—SIDS Susceptibility Pathways—IL6R—osteoporosis	0.000155	0.00135	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—MGLL—osteoporosis	0.000152	0.00132	CbGpPWpGaD
Gallium nitrate—Nausea—Conjugated Estrogens—osteoporosis	0.000151	0.00167	CcSEcCtD
Gallium nitrate—Hypersensitivity—Estradiol—osteoporosis	0.00015	0.00165	CcSEcCtD
Gallium nitrate—TF—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoporosis	0.000149	0.0013	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—LRP5—osteoporosis	0.000149	0.00129	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—P4HB—osteoporosis	0.000148	0.00128	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—GAPDH—osteoporosis	0.000145	0.00126	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—FGA—osteoporosis	0.000145	0.00126	CbGpPWpGaD
Gallium nitrate—Pruritus—Estradiol—osteoporosis	0.000144	0.00159	CcSEcCtD
Gallium nitrate—BGLAP—Glucocorticoid receptor regulatory network—IL6—osteoporosis	0.000143	0.00125	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—LRP6—osteoporosis	0.000142	0.00124	CbGpPWpGaD
Gallium nitrate—Diarrhoea—Estradiol—osteoporosis	0.00014	0.00154	CcSEcCtD
Gallium nitrate—ATP6V1B2—Disease—NFATC1—osteoporosis	0.000138	0.0012	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—DKK1—osteoporosis	0.000137	0.00119	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Transmembrane transport of small molecules—ADCY5—osteoporosis	0.000133	0.00116	CbGpPWpGaD
Gallium nitrate—RRM2—E2F transcription factor network—MYC—osteoporosis	0.000133	0.00116	CbGpPWpGaD
Gallium nitrate—IL1B—Folate Metabolism—TNF—osteoporosis	0.000132	0.00115	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—FGB—osteoporosis	0.000132	0.00115	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—WNT1—osteoporosis	0.000132	0.00115	CbGpPWpGaD
Gallium nitrate—IL1B—Vitamin B12 Metabolism—IL6—osteoporosis	0.000131	0.00114	CbGpPWpGaD
Gallium nitrate—Vomiting—Estradiol—osteoporosis	0.00013	0.00143	CcSEcCtD
Gallium nitrate—Rash—Estradiol—osteoporosis	0.000129	0.00141	CcSEcCtD
Gallium nitrate—Dermatitis—Estradiol—osteoporosis	0.000129	0.00141	CcSEcCtD
Gallium nitrate—ATP6V1B2—Disease—FGA—osteoporosis	0.000128	0.00111	CbGpPWpGaD
Gallium nitrate—IL1B—Allograft Rejection—TGFB1—osteoporosis	0.000123	0.00107	CbGpPWpGaD
Gallium nitrate—Nausea—Estradiol—osteoporosis	0.000121	0.00133	CcSEcCtD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—IL6R—osteoporosis	0.00012	0.00105	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—TLN1—osteoporosis	0.00012	0.00104	CbGpPWpGaD
Gallium nitrate—TF—SIDS Susceptibility Pathways—IL1B—osteoporosis	0.000118	0.00103	CbGpPWpGaD
Gallium nitrate—RRM2—Retinoblastoma (RB) in Cancer—MYC—osteoporosis	0.000116	0.00101	CbGpPWpGaD
Gallium nitrate—TF—Platelet activation, signaling and aggregation—IGF1—osteoporosis	0.000116	0.00101	CbGpPWpGaD
Gallium nitrate—IL1B—Alzheimers Disease—TNF—osteoporosis	0.000114	0.000996	CbGpPWpGaD
Gallium nitrate—IL1B—Allograft Rejection—TNF—osteoporosis	0.000114	0.000996	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—ENO1—osteoporosis	0.000114	0.000993	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—PSMA2—osteoporosis	0.000112	0.000979	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—PSMA5—osteoporosis	0.000112	0.000979	CbGpPWpGaD
Gallium nitrate—IL1B—TCR Signaling Pathway—TGFB1—osteoporosis	0.00011	0.000961	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—FDPS—osteoporosis	0.00011	0.000953	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—PKM—osteoporosis	0.00011	0.000953	CbGpPWpGaD
Gallium nitrate—IL1B—Folate Metabolism—IL6—osteoporosis	0.000107	0.000928	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—PSMA2—osteoporosis	0.000106	0.000923	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—PSMA5—osteoporosis	0.000106	0.000923	CbGpPWpGaD
Gallium nitrate—IL1B—Selenium Micronutrient Network—TNF—osteoporosis	0.000105	0.000914	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—CALCA—osteoporosis	0.000105	0.000912	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—PGLS—osteoporosis	0.000104	0.000904	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—GPD2—osteoporosis	0.000104	0.000904	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—P4HB—osteoporosis	0.000103	0.0009	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—PTH—osteoporosis	0.000101	0.000875	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—RAP1A—osteoporosis	9.89e-05	0.00086	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—CNR2—osteoporosis	9.81e-05	0.000853	CbGpPWpGaD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—TGFB1—osteoporosis	9.77e-05	0.00085	CbGpPWpGaD
Gallium nitrate—RRM2—G1/S Transition—MYC—osteoporosis	9.67e-05	0.000842	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—NFATC1—osteoporosis	9.65e-05	0.000839	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—DKK1—osteoporosis	9.57e-05	0.000833	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—KL—osteoporosis	9.52e-05	0.000828	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—ATIC—osteoporosis	9.5e-05	0.000826	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—PNP—osteoporosis	9.5e-05	0.000826	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—PSMA2—osteoporosis	9.48e-05	0.000825	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—PSMA5—osteoporosis	9.48e-05	0.000825	CbGpPWpGaD
Gallium nitrate—IL1B—Toll-like Receptor Signaling Pathway—TNF—osteoporosis	9.33e-05	0.000812	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—WNT1—osteoporosis	9.22e-05	0.000802	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—IRS2—osteoporosis	9.19e-05	0.0008	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—FGA—osteoporosis	8.97e-05	0.00078	CbGpPWpGaD
Gallium nitrate—IL1B—Spinal Cord Injury—MYC—osteoporosis	8.92e-05	0.000776	CbGpPWpGaD
Gallium nitrate—IL1B—Spinal Cord Injury—TGFB1—osteoporosis	8.89e-05	0.000774	CbGpPWpGaD
Gallium nitrate—TF—SIDS Susceptibility Pathways—TNF—osteoporosis	8.57e-05	0.000745	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—IRAK3—osteoporosis	8.5e-05	0.00074	CbGpPWpGaD
Gallium nitrate—IL1B—Selenium Micronutrient Network—IL6—osteoporosis	8.48e-05	0.000737	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—PTHLH—osteoporosis	8.34e-05	0.000725	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—BMP2—osteoporosis	8.34e-05	0.000725	CbGpPWpGaD
Gallium nitrate—IL1B—TCR Signaling Pathway—IL6—osteoporosis	8.32e-05	0.000724	CbGpPWpGaD
Gallium nitrate—IL1B—Spinal Cord Injury—TNF—osteoporosis	8.31e-05	0.000723	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—FGB—osteoporosis	8.16e-05	0.00071	CbGpPWpGaD
Gallium nitrate—RRM2—Mitotic G1-G1/S phases—MYC—osteoporosis	8.15e-05	0.000709	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—OXCT1—osteoporosis	8.08e-05	0.000703	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—CA2—osteoporosis	8.08e-05	0.000703	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—IRS1—osteoporosis	8.02e-05	0.000698	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—PSMA2—osteoporosis	7.88e-05	0.000685	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—PSMA5—osteoporosis	7.88e-05	0.000685	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—MGLL—osteoporosis	7.87e-05	0.000685	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—ACTG1—osteoporosis	7.78e-05	0.000676	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—IL6R—osteoporosis	7.54e-05	0.000656	CbGpPWpGaD
Gallium nitrate—IL1B—Toll-like Receptor Signaling Pathway—IL6—osteoporosis	7.53e-05	0.000655	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—ADCY5—osteoporosis	7.46e-05	0.000649	CbGpPWpGaD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—IL6—osteoporosis	7.36e-05	0.00064	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—CALCA—osteoporosis	7.34e-05	0.000639	CbGpPWpGaD
Gallium nitrate—TF—Transmembrane transport of small molecules—ADCY5—osteoporosis	7.3e-05	0.000635	CbGpPWpGaD
Gallium nitrate—IL1B—Regulation of toll-like receptor signaling pathway—TNF—osteoporosis	7.29e-05	0.000634	CbGpPWpGaD
Gallium nitrate—IL1B—Signaling by Interleukins—IL6—osteoporosis	7.19e-05	0.000626	CbGpPWpGaD
Gallium nitrate—TF—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	6.94e-05	0.000604	CbGpPWpGaD
Gallium nitrate—TF—SIDS Susceptibility Pathways—IL6—osteoporosis	6.91e-05	0.000601	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—MTHFR—osteoporosis	6.86e-05	0.000597	CbGpPWpGaD
Gallium nitrate—IL1B—MAPK Signaling Pathway—MYC—osteoporosis	6.72e-05	0.000585	CbGpPWpGaD
Gallium nitrate—IL1B—MAPK Signaling Pathway—TGFB1—osteoporosis	6.7e-05	0.000583	CbGpPWpGaD
Gallium nitrate—IL1B—Spinal Cord Injury—IL6—osteoporosis	6.7e-05	0.000583	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—IDH2—osteoporosis	6.69e-05	0.000582	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—KL—osteoporosis	6.67e-05	0.00058	CbGpPWpGaD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—TNF—osteoporosis	6.64e-05	0.000578	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—IRS2—osteoporosis	6.52e-05	0.000568	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—RAP1A—osteoporosis	6.5e-05	0.000565	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—CTSK—osteoporosis	6.44e-05	0.000561	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—NFATC1—osteoporosis	6.34e-05	0.000551	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—CYP27A1—osteoporosis	6.29e-05	0.000547	CbGpPWpGaD
Gallium nitrate—IL1B—MAPK Signaling Pathway—TNF—osteoporosis	6.26e-05	0.000545	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—ACP5—osteoporosis	6.12e-05	0.000533	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—IGF1—osteoporosis	5.97e-05	0.000519	CbGpPWpGaD
Gallium nitrate—IL1B—Regulation of toll-like receptor signaling pathway—IL6—osteoporosis	5.88e-05	0.000511	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—IRS1—osteoporosis	5.7e-05	0.000495	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—TPI1—osteoporosis	5.69e-05	0.000495	CbGpPWpGaD
Gallium nitrate—IL1B—Myometrial Relaxation and Contraction Pathways—IL6—osteoporosis	5.39e-05	0.000469	CbGpPWpGaD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—IL6—osteoporosis	5.36e-05	0.000466	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—P4HB—osteoporosis	5.35e-05	0.000466	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—IL6R—osteoporosis	5.35e-05	0.000465	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—GAPDH—osteoporosis	5.25e-05	0.000457	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—ADCY5—osteoporosis	5.22e-05	0.000454	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—PSMA2—osteoporosis	5.18e-05	0.00045	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—PSMA5—osteoporosis	5.18e-05	0.00045	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—RAP1A—osteoporosis	5.12e-05	0.000445	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—SPP1—osteoporosis	5.05e-05	0.000439	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—IRS2—osteoporosis	4.57e-05	0.000397	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—LEP—osteoporosis	4.47e-05	0.000389	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—KL—osteoporosis	4.38e-05	0.000381	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—ESR1—osteoporosis	4.27e-05	0.000371	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—ENO1—osteoporosis	4.14e-05	0.00036	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—PSMA2—osteoporosis	4.07e-05	0.000354	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—PSMA5—osteoporosis	4.07e-05	0.000354	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—IRS1—osteoporosis	3.99e-05	0.000347	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—POMC—osteoporosis	3.84e-05	0.000334	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—IL6R—osteoporosis	3.75e-05	0.000326	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—IGF1—osteoporosis	3.69e-05	0.000321	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—TGFB1—osteoporosis	3.58e-05	0.000311	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—AGER—osteoporosis	3.44e-05	0.0003	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—ADCY5—osteoporosis	3.43e-05	0.000298	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—IL6—osteoporosis	3.36e-05	0.000292	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—CYP19A1—osteoporosis	3.31e-05	0.000288	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—MYC—osteoporosis	3.17e-05	0.000276	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—TGFB1—osteoporosis	3.16e-05	0.000275	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—IRS2—osteoporosis	3e-05	0.000261	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—MYC—osteoporosis	2.99e-05	0.00026	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—ADCY5—osteoporosis	2.7e-05	0.000235	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—GPX1—osteoporosis	2.69e-05	0.000234	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—MYC—osteoporosis	2.67e-05	0.000233	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—IRS1—osteoporosis	2.62e-05	0.000228	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—MTHFR—osteoporosis	2.48e-05	0.000216	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—IL6R—osteoporosis	2.46e-05	0.000214	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—IL6—osteoporosis	2.38e-05	0.000207	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—MYC—osteoporosis	2.22e-05	0.000193	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—TGFB1—osteoporosis	2.21e-05	0.000193	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—POMC—osteoporosis	1.99e-05	0.000173	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—IL6—osteoporosis	1.67e-05	0.000145	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—IL6—osteoporosis	1.1e-05	9.54e-05	CbGpPWpGaD
